Top Legislation - View All
Also tagged in: Business, Cytology, Donation of organs, tissues, etc., Genetic research, Income tax, Medical care, Medical research, Medicine, Research and development tax credit, Science policy, Storage, Tax credits, Taxation
Latest Action: 01/12/2007 - Sponsor introductory remarks on measure. (CR E93) Bill TextTo amend the Internal Revenue Code of 1986 to provide credits against income tax for qualified stem cell research, the storage of qualified stem cells, and the donation of umbilical cord blood. 1/12/2007--Introduced. Cures Can Be Found Act of 2007 - Amends the Internal Revenue Code to allow tax credits for donations: (1) to stem cell research or storage facilities; (2) of umbilical cord blood. Allows credits only for donations to facilities that do not engage in research on stem cells derived from human embryos. Allows a business tax credit for stem cell research and storage expenses.
Latest Action: 01/04/2007 - Referred to the House Committee on Ways and Means. Bill TextTo amend the Internal Revenue Code of 1986 to allow a credit against tax for expenses related to the collection and storage of umbilical cord blood. 1/4/2007--Introduced. Amends the Internal Revenue Code to allow a tax credit for 50% of qualified umbilical cord blood collection and storage expenses, up to $2,000 in a taxable year. Defines "qualified umbilical cord blood collection and storage expenses" as expenses directly related to the collection, storage, and maintenance of umbilical cord blood collected at the birth of a child.
Also tagged in: Blood tests, Budgets, Clinical trials, Data banks, Epidemiology, Executive departments, Federal advisory bodies, Federal aid to health facilities, Federal aid to research, Health policy, Laboratories, Medical care, Medical research, Medical screening, Medical statistics, Medical tests, Medicine, Nonprofit organizations, Ovarian cancer, Research centers, Research grants, Risk, Science policy, Social services, Technology, Tissue banks, Urinalysis, Women, Women's health, Women's health services
Latest Action: 11/08/2007 - Referred to the Subcommittee on Health. Bill TextTo amend the Public Health Service Act to authorize the Director of the National Cancer Institute to make grants for the discovery and validation of biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer. 9/27/2007--Introduced. Ovarian Cancer Biomarker Research Act of 2007 - Amends the Public Health Service Act to require the Director of the National Cancer Institute to enter into cooperative agreements with, or make grants to, public or nonprofit entities to establish and operate centers to conduct research on biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer. Designates each center as an Ovarian Cancer Biomarker Center of Excellence.Allows federal payments under such an agreement or grant to be used for research on: (1) the development and characterization of new biomarkers and the refinement of existing biomarkers; (2) the clinical and laboratory validation of such [...] show full description
Also tagged in: Blood tests, Budgets, Clinical trials, Data banks, Epidemiology, Executive departments, Federal advisory bodies, Federal aid to health facilities, Federal aid to research, Health policy, Laboratories, Medical care, Medical research, Medical screening, Medical statistics, Medical tests, Medicine, Nonprofit organizations, Ovarian cancer, Research centers, Research grants, Risk, Science policy, Social services, Technology, Tissue banks, Urinalysis, Women, Women's health, Women's health services
Latest Action: 01/29/2008 - Sponsor introductory remarks on measure. (CR S448) Bill TextA bill to amend the Public Health Service Act to authorize the Director of the National Cancer Institute to make grants for the discovery and validation of biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer. 1/29/2008--Introduced. Ovarian Cancer Biomarker Research Act of 2008 - Amends the Public Health Service Act to require the Director of the National Cancer Institute to enter into cooperative agreements with, or make grants to, public or nonprofit entities to establish and operate centers to conduct research on biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer. Designates each center as an Ovarian Cancer Biomarker Center of Excellence.Allows federal payments under such an agreement or grant to be used for research on: (1) the development and characterization of new biomarkers and the refinement of existing biomarkers; (2) the clinical and laboratory validation [...] show full description
|
Latest Legislation - View All
Also tagged in: Blood tests, Budgets, Clinical trials, Data banks, Epidemiology, Executive departments, Federal advisory bodies, Federal aid to health facilities, Federal aid to research, Health policy, Laboratories, Medical care, Medical research, Medical screening, Medical statistics, Medical tests, Medicine, Nonprofit organizations, Ovarian cancer, Research centers, Research grants, Risk, Science policy, Social services, Technology, Tissue banks, Urinalysis, Women, Women's health, Women's health services
Latest Action: 01/29/2008 - Sponsor introductory remarks on measure. (CR S448) Bill TextA bill to amend the Public Health Service Act to authorize the Director of the National Cancer Institute to make grants for the discovery and validation of biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer. 1/29/2008--Introduced. Ovarian Cancer Biomarker Research Act of 2008 - Amends the Public Health Service Act to require the Director of the National Cancer Institute to enter into cooperative agreements with, or make grants to, public or nonprofit entities to establish and operate centers to conduct research on biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer. Designates each center as an Ovarian Cancer Biomarker Center of Excellence.Allows federal payments under such an agreement or grant to be used for research on: (1) the development and characterization of new biomarkers and the refinement of existing biomarkers; (2) the clinical and laboratory validation [...] show full description
Also tagged in: Blood tests, Budgets, Clinical trials, Data banks, Epidemiology, Executive departments, Federal advisory bodies, Federal aid to health facilities, Federal aid to research, Health policy, Laboratories, Medical care, Medical research, Medical screening, Medical statistics, Medical tests, Medicine, Nonprofit organizations, Ovarian cancer, Research centers, Research grants, Risk, Science policy, Social services, Technology, Tissue banks, Urinalysis, Women, Women's health, Women's health services
Latest Action: 11/08/2007 - Referred to the Subcommittee on Health. Bill TextTo amend the Public Health Service Act to authorize the Director of the National Cancer Institute to make grants for the discovery and validation of biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer. 9/27/2007--Introduced. Ovarian Cancer Biomarker Research Act of 2007 - Amends the Public Health Service Act to require the Director of the National Cancer Institute to enter into cooperative agreements with, or make grants to, public or nonprofit entities to establish and operate centers to conduct research on biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer. Designates each center as an Ovarian Cancer Biomarker Center of Excellence.Allows federal payments under such an agreement or grant to be used for research on: (1) the development and characterization of new biomarkers and the refinement of existing biomarkers; (2) the clinical and laboratory validation of such [...] show full description
Also tagged in: Business, Cytology, Donation of organs, tissues, etc., Genetic research, Income tax, Medical care, Medical research, Medicine, Research and development tax credit, Science policy, Storage, Tax credits, Taxation
Latest Action: 01/12/2007 - Sponsor introductory remarks on measure. (CR E93) Bill TextTo amend the Internal Revenue Code of 1986 to provide credits against income tax for qualified stem cell research, the storage of qualified stem cells, and the donation of umbilical cord blood. 1/12/2007--Introduced. Cures Can Be Found Act of 2007 - Amends the Internal Revenue Code to allow tax credits for donations: (1) to stem cell research or storage facilities; (2) of umbilical cord blood. Allows credits only for donations to facilities that do not engage in research on stem cells derived from human embryos. Allows a business tax credit for stem cell research and storage expenses.
Latest Action: 01/04/2007 - Referred to the House Committee on Ways and Means. Bill TextTo amend the Internal Revenue Code of 1986 to allow a credit against tax for expenses related to the collection and storage of umbilical cord blood. 1/4/2007--Introduced. Amends the Internal Revenue Code to allow a tax credit for 50% of qualified umbilical cord blood collection and storage expenses, up to $2,000 in a taxable year. Defines "qualified umbilical cord blood collection and storage expenses" as expenses directly related to the collection, storage, and maintenance of umbilical cord blood collected at the birth of a child.
|
